Robin Swartz, Chief Operating Officer at Voyager Therapeutics, Inc. (VYGR), sold 4,413 shares at $8.68 ($37K) on 2022-03-21, disclosed to the SEC on 2022-03-23.
Scheduled sale ($37k) by Chief Operating Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.29 | 4,362 | $36K | 98.8% |
| 2 | $8.68 | 51 | $443 | 1.2% |
| Total | $8.29 avg | 4,413 | $37K | 100% |
| Filing → |
| VYGR | SELL | 2026-02-11 | $18K | — | Filing → |
| VYGR | SELL | 2025-02-24 | $17K | — | Filing → |
| VYGR | SELL | 2025-02-12 | $31K | — | Filing → |